Dr. Ashwini Sahni

Dr. Anne Marie Valente is the co-director of the Pregnancy and Cardiovascular Disease Program at Brigham and Women’s Hospital and outpatient director of the Boston Adult Congenital Heart Disease & Pulmonary Hypertension Program. A cardiovascular medicine and adult congenital heart disease specialist, she is also an associate professor of medicine and pediatrics at Harvard Medical School. Dr. Valente is the director of the Adult Congenital Heart Disease and Pulmonary Hypertension Senior Fellowship Program at Harvard Medical School.She received her medical degree from University of Vermont College of Medicine. She completed a combined internal medicine/pediatrics residency, as well as pediatric cardiology, adult cardiovascular disease and cardiovascular magnetic resonance imaging fellowships at Duke University Medical Center. Dr. Valente is board certified in internal medicine, pediatrics, cardiovascular disease and pediatric cardiology.Dr. Valente’s clinical and research interests focus on adult congenital heart disease. Her current research examines heart failure complications in patients with repaired tetralogy of Fallot, a congenital heart defect. She has authored over 50 peer-reviewed publications, as well as numerous chapters and reviews about congenital heart disease imaging and the care of women with heart disease during pregnancy. She has received institutional recognition with the Lerner Research Award and the Watkins Discovery Award as well as research funding from the American Heart Association, the Children’s Miracle Network and the National Heart, Lung and Blood Institute.**The BACH program has been training clinicians in the care of adults with congenital heart disease for several decades.  For more information about the Adult Congenital Heart Disease and Pulmonary Hypertension Senior Fellowship Program at Harvard Medical School, please visit the program website.**The BACH program is closely integrated in the Pregnancy and Cardiovascular Disease Program.  This program involves a multi-disciplinary team dedicated to caring for women with heart disease during pregnancy. More information may be found here. Dr. Valente is rated as an Elite provider by MediFind in the treatment of Congenital Heart Disease (CHD). Her top areas of expertise are Tetralogy of Fallot, Congenital Heart Disease (CHD), Ebstein's Anomaly, Cardiac Ablation, and Heart Transplant.

Dr. Michael J. Landzberg is the organizing founder and director of the Boston Adult Congenital Heart and Pulmonary Hypertension Group (BACH) at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also an associate professor of medicine at Harvard Medical School (HMS).Dr. Landzberg received his medical degree from HMS. He completed a residency in internal medicine at Columbia-Presbyterian Medical Center and a fellowship in cardiovascular disease at BWH. Dr. Landzberg is board certified in internal medicine.Dr. Landzberg’s clinical interests include adult congenital heart disease and pulmonary hypertension. The author of more than 140 peer-reviewed publications, Dr. Landzberg’s research focuses on the management of congenital heart disease. Dr. Landzberg is rated as a Distinguished provider by MediFind in the treatment of Congenital Heart Disease (CHD). His top areas of expertise are Congenital Heart Disease (CHD), Tetralogy of Fallot, Eisenmenger Syndrome, Heart Transplant, and Patent Foramen Ovale Repair.

Dr. Christine E. Seidman is the director of the Cardiovascular Genetics Program and a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). In addition, she is the Thomas W. Smith Professor of Medicine at Harvard Medical School.She received her medical degree from The George Washington School of Medicine and Health Sciences. She completed an internal medicine residency at The Johns Hopkins Hospital and a cardiology fellowship at Massachusetts General Hospital. Dr. Seidman is board certified in internal medicine and cardiovascular disease. Her clinical interests include cardiovascular medicine and genetics.Dr. Seidman also leads the Seidman Laboratory to elucidate genetic causes for heart disease and other disorders. Notable achievements include the discovery of the first genetic cause of congenital heart malformations. Dr. Seidman promotes collaboration between the Laboratory and the BWH Cardiovascular Genetics Center to translate research discoveries into better diagnostics and improved management strategies. She has authored over 300 peer-reviewed articles and received research funding from the Howard Hughes Medical Institute and National Institutes of Health. Dr. Seidman is rated as a Distinguished provider by MediFind in the treatment of Congenital Heart Disease (CHD). Her top areas of expertise are Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Heart Transplant, and Heart Bypass Surgery.